biote Corp. (BTMD) is a Healthcare stock trading at $2.26 (as of 2026-06-18), with a market capitalization of $77.39M and a trailing P/E of 5.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
biote Corp. provides services and products used by Biote-certified practitioners to evaluate and support patients’ hormone, vitamin, and mineral levels and to prescribe bioidentical hormone therapies along with dietary supplements. The company also sells Biote-branded supplements and sterile pellet insertion kits for men and women.